To stay healthy, our cells rely on a self-cleaning mechanism that removes defective or unnecessary components. This process, ...

EpiBiologics launched in 2023 with a $50 million series A, having been founded to take forward the work of renowned antibody ...

Individual mammalian cells contain billions of protein molecules, which must be synthesized, deployed, and removed with ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

Targeted protein degradation has moved well beyond its prologue more than 20 years ago. 1 The number of publications describing different PROTACs (PROteolysis TArgeting Chimeras), molecular glues, and ...

Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...

When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, ...

Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding EnodiaFinancing ...

Muscle cells contain their own circadian clocks and disrupting them with shift work can have a profound impact on aging, according to the results of a preclinical study carried out by Jeffrey Kelu, ...

Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...